Cargando…
c-Jun N-Terminal Kinase Signaling Inhibitors Under Development
Targeting protein kinases has been active area in drug discovery. The c-Jun N-terminal kinases (JNKs) have also been target for development of novel therapy in various diseases, since the roles of JNK signaling in pathological conditions were revealed in studies using jnk-deficient mice. Small molec...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006258/ https://www.ncbi.nlm.nih.gov/pubmed/32038782 http://dx.doi.org/10.5487/TR.2008.24.2.093 |